secwatch / observer
8-K filed October 23, 2023, 7:59 PM ET ticker ASPI CIK 0001921865
leadership confidence high sentiment neutral materiality 0.30

ASP Isotopes appoints Prof. Mike Gorley to board; achieves independent majority

ASP Isotopes Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sergey Vasnetsov

Director
ASPI · ASP Isotopes Inc.
Effective
2023-10-23
Successor
Professor Mike Gorley
Filed
October 23, 2023, 7:59 PM ET
On October 19, 2023, Sergey Vasnetsov provided notice to the Company of his decision to voluntarily step down from the Company’s board of directors, effective October 23, 2023.
Appointed

Professor Mike Gorley

Director
ASPI · ASP Isotopes Inc.
Effective
2023-10-23
Filed
October 23, 2023, 7:59 PM ET
the Board appointed Professor Mike Gorley to serve as a director of the Company, effective immediately following Mr. Vasnetsov’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sergey Vasnetsov resigned as Director at ASP Isotopes Inc..

Action
resigned
Role
Director
Exact text from the filing
On October 19, 2023, Sergey Vasnetsov provided notice to the Company of his decision to voluntarily step down from the Company’s board of directors, effective October 23, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Professor Mike Gorley was appointed as Director at ASP Isotopes Inc..

Action
appointed
Role
Director
Exact text from the filing
the Board appointed Professor Mike Gorley to serve as a director of the Company, effective immediately following Mr. Vasnetsov’s resignation.
View on SEC.gov

ASP Isotopes Inc. filing history →

Source: SEC EDGAR
accession 0001477932-23-007809
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.